Business
Eupraxia Pharmaceuticals raises USD 55m in public offering
Canada-based Eupraxia Pharmaceuticals Inc. (Nasdaq: EPRX / TSX: EPRX) announced the pricing of a public offering of common shares and pre-funded warrants...
Frontier Biotech and GSK sign USD 1b. exclusive licensing deal for siRNA kidney disease therapies
Frontier Biotechnologies Inc., a Nanjing, China-headquartered biopharma company, announced an exclusive licensing agreement with GSK, the London-based...
Quotient Therapeutics and Merck launch USD 2.2b somatic genomics collaboration for IBD drug targets
Quotient Therapeutics and Merck have entered a multi-year research collaboration to discover novel drug targets in inflammatory bowel disease using...
SK Bioscience Secures USD 3M RIGHT Foundation Grant to Advance RSV Antibody Development
SK bioscience, a vaccine and biotechnology company headquartered in Incheon, South Korea, has secured KRW 4 billion (approximately USD 3.0 million) from the...
Starget Pharma Closes USD 18 Million Series A to Advance AI-Driven Radioligand Therapy Pipeline
Starget Pharma Inc., a clinical-stage radiopharmaceutical company with operations in the United States and Israel, has closed a USD 18 million Series A...
Unnatural Products and Novartis sign USD 1.8b macrocyclic peptide deal for cardiovascular disease
Unnatural Products, Inc. (UNP), a privately held biotechnology company headquartered in Santa Cruz, California, announced a research collaboration and...
Monash University and ClinChoice partner to accelerate early-phase clinical trials across multiple therapeutic areas
Monash University and ClinChoice Enter Clinical Development Partnership Focused on Early-Phase Trials
Angitia Biopharmaceuticals Raises $130M in Series D to Advance Musculoskeletal Disease Therapies
Angitia Biopharmaceuticals Secures USD 130 Million in Series D Financing to Advance Musculoskeletal Therapeutics
Relmada Therapeutics raises USD 160m in oversubscribed private placement financing
Relmada Therapeutics, Inc. (Nasdaq: RLMD), a clinical-stage company based in Coral Gables, Florida, announced a private placement financing expected to...
LB Pharmaceuticals raises USD 100m in strategic private placement
LB Pharmaceuticals Secures $100 Million in Strategic Private Placement Financing
Tempest Therapeutics selects Cincinnati Children's AGCTC for TPST-2003 CAR-T manufacturing partnership
Tempest Therapeutics, Inc. (Brisbane, California; Nasdaq: TPST) selected Cincinnati Children's Applied Gene and Cell Therapy Center (AGCTC) (Cincinnati,...
Cancer Grand Challenges Awards USD 125M in Series Grants to Five Global Research Teams
Cancer Grand Challenges Awards USD 125m to Five Global Research Teams
Turn Therapeutics Secures Up to $25 Million in Growth Capital to Advance Dermatology Pipeline
Turn Therapeutics, a clinical-stage dermatology company headquartered in Los Angeles, has secured up to USD 25 million in growth capital financing from...
OPKO Health and Entera Bio Expand $50M Oral Peptide Therapy Partnership
OPKO Health, Entera Bio Expand Partnership to Advance Oral Peptide Therapies
Novartis to acquire Synnovation Therapeutics PI3Kα inhibitor program for up to USD 3b.
Novartis has agreed to acquire Pikavation Therapeutics, a wholly-owned subsidiary of Synnovation Therapeutics, to gain control of SNV4818 and related PI3Kα...
The AllSci Brief
Systematic R&D and deal news. Daily.